Last Updated: 14 Sep 2024
Executive Summary
Universal Health Services Inc. (UHS) is a leading provider of hospital and healthcare services in the United States. The company has a strong financial position with a market capitalization of $15.5 billion and a trailing P/E ratio of 17.1. UHS has a positive long-term outlook due to its strong fundamentals and favorable industry trends.
Company Overview
Universal Health Services Inc. is a publicly traded company headquartered in King of Prussia, Pennsylvania. The company operates over 400 hospitals and healthcare facilities in the United States, United Kingdom, and Puerto Rico. UHS provides a wide range of services, including acute care, behavioral health, and ambulatory care.
Fundamental Analysis
UHS has a strong financial position with a revenue of $15.0 billion and an EBITDA of $2.0 billion in the past year. The company has a net income margin of 6.2% and a return on equity of 14.9%. UHS has a strong balance sheet with $3.5 billion in cash and equivalents and $4.5 billion in debt.
Technical Analysis
UHS's stock price has been in a bullish trend since the beginning of the year. The stock is currently trading above its 50-day and 200-day moving averages. The relative strength index (RSI) is above 50, indicating that the stock is in a bullish trend.
Short Term Outlook
UHS's stock price is expected to continue to rise in the short term. The company has a strong financial position and is benefiting from favorable industry trends. The stock is currently trading at a discount to its analyst target price of $240.13.
Long Term Outlook
UHS has a positive long-term outlook. The company is well-positioned to benefit from the aging population and the increasing demand for healthcare services. The company is also investing in new technologies and expanding its geographic reach.
Analyst Recommendations
Analysts are bullish on UHS. The consensus analyst rating is "Buy". Four analysts have a "Strong Buy" rating, six analysts have a "Buy" rating, and nine analysts have a "Hold" rating. The average analyst target price is $240.13.
